EX-99.1 6 lifeway_ex9901.htm PRESS RELEASE

EXHIBIT 99.1

 

Lifeway Foods EPS Increases 44% Year-Over-Year as Kefir Company Announces Results for the First Quarter Ended March 31, 2025

 

Net sales of $46.1 million; up 3.3% year-over-year

 

Consumer demand for probiotic Lifeway products drives 22nd consecutive quarter of year-over-year sales growth

 

Morton Grove, IL — May 13, 2025 — Lifeway Foods, Inc. (Nasdaq: LWAY) (“Lifeway” or “the Company”), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, reported financial results for the first quarter ended March 31, 2025.

 

“We’re thrilled to begin 2025 with continued topline momentum, delivering our 22nd consecutive quarter of year-over-year net sales growth,” commented Julie Smolyansky, President and Chief Executive Officer of Lifeway Foods. “Our Q1 performance builds on the foundation of our record-breaking 2024, as we continued to see consistent volume growth in our flagship drinkable Lifeway Kefir. Our topline growth follows a very strong first quarter in 2024 in which we delivered 18% growth. There are several important factors that highlight the underlying strength of the business that led to year-over-year growth. First, in the second half of last year we strategically eliminated a retail relationship to prioritize our branded offerings over private label and enhance our margins. Additionally, a sizeable distributor adjusted orders from delivery to direct pick-ups in late 2024, this leads to lower billed sales and correspondingly lower freight costs. Excluding the impact from both of these strategic adjustments, on a like-for-like basis, we delivered nearly 11% volume-led growth in the quarter, underscoring the power of our Lifeway branded products and the loyalty of our growing customer base.” added Ms. Smolyansky.

 

Ms. Smolyansky continued, “The accelerating consumer focus on health and wellness continues to be a tailwind for our business, with demand rising for protein-rich, probiotic and bioavailable foods, including our Lifeway Kefir and Farmer Cheese. Our strategic sales and marketing investments are clearly paying dividends, driving increased brand recognition, strong product velocities, and introducing the Lifeway brand to more and more customers who value premium, nutritious offerings. We see no impact of tariffs on our business at this time or in the foreseeable future. We expect consumer visits to grocery and club stores to increase amid tightening consumer spending, as shoppers seek better-for-you and nutritionally valuable foods and beverages, such as the highly bioavailable protein options and gut-healthy products that Lifeway offers. This focus on protein, gut health and select nutrients is especially true for consumers currently using GLP-1 medications and those who are looking for foods that naturally stimulate GLP-1 hormone production. As a result, our target addressable market has rapidly grown, and we are successfully capitalizing on that trend alongside our retailer partners through expanded distribution of our key products. This year we have received commitments at key retailers for more than 2,000 total incremental points of distribution across our product lines, including Lifeway Farmer Cheese, our new Flavor Fusions and our Probiotic Smoothies with Collagen. Lifeway products can also now be found in 40 airports across the country. Notably, in the last full week of April, we surpassed $5 million in gross sales, a record week for our business, propelled by demand for Lifeway Kefir and Farmer Cheese. The second quarter is off to a good start, and we plan to continue our investments behind our core branded products in 2025 to further capitalize on the tremendous market opportunity in front of us and extend upon the vast momentum we have achieved.”

 

First Quarter 2025 Results

 

Net sales were $46.1 million for the first quarter ended March 31, 2025, an increase of $1.5 million or 3.3% from the same period in 2024. The net sales increase was primarily driven by higher volumes of Lifeway’s branded drinkable kefir.

 

Gross profit as a percentage of net sales was 24.0% for the first quarter ended March 31, 2025.

 

Selling, general and administrative expenses as a percentage of net sales was 20.2% for the first quarter ended March 31, 2025.

 

 

 

 1 

 

 

The Company reported net income of $3.5 million or $0.23 per basic and diluted common share for the first quarter ended March 31, 2025.

 

We remain confident that the Company is on track to deliver Adjusted EBITDA1 of $45 - $50mm in FY2027.

 

1.Adjusted EBITDA is a non-GAAP financial measure. Adjusted EBITDA is defined as Operating Income, as reported, plus Depreciation and Amortization, plus Stock-Based Compensation.

 

The Company does not provide guidance for GAAP Operating Income, nor a reconciliation of any forward-looking non-GAAP financial measures to the most directly comparable GAAP financial measures on a forward-looking basis, because it is unable to predict certain items contained in the GAAP measures without unreasonable efforts. These forward-looking non-GAAP financial measures do not include certain items, which may be significant, including, without limitation, non-recurring or non-operational expenses such as stock-based compensation, gain/loss on sale of equipment, deferred revenue and gain/loss on investments prior to payment of bonuses to employees.

 

Conference Call and Webcast

 

A webcast with Lifeway’s President and Chief Executive Officer discussing these results with additional comments and details is available through the “Investor Relations” section of the Company’s website at https://lifewaykefir.com/webinars-reports/.

 

About Lifeway Foods, Inc.

 


Lifeway Foods, Inc., which has been recognized as one of Forbes' Best Small Companies, is America's leading supplier of the probiotic, fermented beverage known as kefir. In addition to its line of drinkable kefir, the company also produces a variety of cheeses and a ProBugs line for kids. Lifeway's tart and tangy fermented dairy products are now sold across the United States, Mexico, Ireland, South Africa, United Arab Emirates, and France. Learn how Lifeway is good for more than just you at lifewayfoods.com.

 

Forward-Looking Statements

 

This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 regarding, among other things, the drivers of demand for Lifeway’s products, consumer trends, the anticipated effects of scheduled upgrades at the Waukesha plant, expected operating efficiencies and expectations regarding future operating and financial performance. These statements use words, and variations of words, such as “will,” "continue," "future," "increase," "believe," "outlook," "expect," and "predict." You are cautioned not to rely on these forward-looking statements. These forward-looking statements are made as of the date of this press release, are based on current expectations of future events and thus are inherently subject to a number of risks and uncertainties, many of which involve factors or circumstances beyond Lifeway’s control. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from Lifeway's expectations and projections. These risks, uncertainties, and other factors include: price competition; the decisions of customers or consumers; the actions of competitors; changes in the pricing of commodities; the effects of government regulation; possible delays in the introduction of new products; customer acceptance of products and services; and uncertainty regarding proposals or other actions taken by shareholders related to the unsolicited proposal made by Danone North America PBC (“Danone”) to acquire all of the shares of Lifeway stock that Danone does not already own. A further list and description of these risks, uncertainties, and other factors can be found in Lifeway's Annual Report on Form 10-K for the fiscal year ended December 31, 2024. Copies of these filings are available online at https://www.sec.gov, http://lifewaykefir.com/investor-relations/, or on request from Lifeway. Lifeway expressly disclaims any obligation to update any forward-looking statements (including, without limitation, to reflect changed assumptions, the occurrence of anticipated or unanticipated events or new information), except as required by law.

 

 

 

 2 

 

 

Non-GAAP Financial Measures

 

This press release refers to Adjusted EBITDA, which is a financial measure that has not been prepared in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”), and may exclude items that are significant to understanding and assessing financial results. This non-GAAP measure is provided to enhance investors’ overall understanding of the Company’s financial performance. Non-GAAP financial measures should be considered as supplements to GAAP measures reported, should not be considered replacements for, or superior to, GAAP measures reported and may not be comparable to similarly named measures used by other companies. The Company’s calculation of non-GAAP financial measures may differ from methods used by other companies.

 

Perceptual Advisors
Dan Tarman
Email: [email protected]

 
Derek Miller
Vice President of Communications, Lifeway Foods
Email: [email protected]

 

General inquiries:
Lifeway Foods, Inc.
Phone: 847-967-1010
Email: [email protected]

 

 

 

 

 

 

 

 

 

 3 

 

 

LIFEWAY FOODS, INC. AND SUBSIDIARIES

Consolidated Balance Sheets

March 31, 2025 and December 31, 2024

(In thousands)

 

 

   March 31, 2025   December 31, 
   (Unaudited)   2024 
Current assets          
Cash and cash equivalents  $19,446   $16,728 
Accounts receivable, net of allowance for credit losses and discounts & allowances of $2,030 and $1,590 at March 31, 2025 and December 31, 2024, respectively   16,684    15,424 
Inventories, net   9,241    8,678 
Prepaid expenses and other current assets   2,007    2,144 
Refundable income taxes       631 
Total current assets   47,378    43,605 
           
Property, plant and equipment, net   28,112    26,862 
Operating lease right-of-use asset   109    118 
Goodwill   11,704    11,704 
Intangible assets, net   6,223    6,358 
Other assets   141    1,900 
Total assets  $93,667   $90,547 
           
Current liabilities          
Accounts payable  $11,635   $10,401 
Accrued expenses   3,939    5,103 
Accrued income taxes   795     
Total current liabilities   16,369    15,504 
Operating lease liabilities   68    70 
Deferred income taxes, net   3,062    3,062 
Total liabilities   19,499    18,636 
           
Stockholders’ equity          
Preferred stock, no par value; 2,500 shares authorized; none issued        
Common stock, no par value; 40,000 shares authorized; 17,274 shares issued; 15,203 and 15,100 outstanding at March 31, 2025 and December 31, 2024, respectively   6,509    6,509 
Treasury stock, at cost   (13,383)   (14,052)
Paid-in capital   2,680    4,632 
Retained earnings   78,362    74,822 
Total stockholders’ equity   74,168    71,911 
           
Total liabilities and stockholders’ equity  $93,667   $90,547 

 

 

 

 4 

 

 

LIFEWAY FOODS, INC. AND SUBSIDIARIES

Consolidated Statements of Operations

For the three months ended March 31, 2025 and 2024

(Unaudited)

(In thousands, except per share data)

 

 

   2025   2024 
Net Sales  $46,091   $44,634 
           
Cost of goods sold   34,254    32,438 
Depreciation expense   802    661 
Total cost of goods sold   35,056    33,099 
           
Gross profit   11,035    11,535 
           
Selling expense   4,698    3,700 
General and administrative expense   4,628    4,136 
Amortization expense   135    135 
Total operating expenses   9,461    7,971 
           
Income from operations   1,574    3,564 
           
Other income (expense):          
Interest expense   (14)   (51)
Gain on sales of investments   3,352     
Other income (expense), net   54    (5)
Total other income (expense)   3,392    (56)
           
Income before provision for income taxes   4,966    3,508 
           
Provision for income taxes   1,426    1,082 
           
Net income  $3,540   $2,426 
           
Net earnings per common share:          
Basic  $0.23   $0.17 
Diluted  $0.23   $0.16 
           
Weighted average common shares outstanding:          
Basic   15,134    14,691 
Diluted   15,333    15,222 

 

 

 

 5 

 

 

LIFEWAY FOODS, INC. AND SUBSIDIARIES

Unaudited Consolidated Statements of Cash Flows

(Unaudited)

(In thousands)

 

 

   Three months ended March 31, 
   2025   2024 
Cash flows from operating activities:          
Net income  $3,540   $2,426 
Adjustments to reconcile net income to operating cash flow:          
Depreciation and amortization   937    796 
Stock-based compensation   326    673 
Non-cash interest expense   3    2 
Gain on sale of investments   (3,352)    
Fair value loss on investment   20     
(Increase) decrease in operating assets:          
Accounts receivable   (1,259)   (1,189)
Inventories   (563)   974 
Prepaid expenses and other current assets   136    31 
Refundable income taxes   631    (378)
Increase (decrease) in operating liabilities:          
Accounts payable   1,401    (6)
Accrued expenses   (2,765)   (1,309)
Accrued income taxes   795    (474)
Net cash (used in) provided by operating activities   (150)   1,546 
           
Cash flows from investing activities:          
Purchases of property and equipment   (2,219)   (2,469)
Proceeds from sale of investments   5,152     
Net cash provided by (used in) investing activities   2,933    (2,469)
           
Cash flows from financing activities:          
Repayment of note payable       (250)
Payment of deferred financing costs   (65)    
Net cash used in financing activities   (65)   (250)
           
Net increase (decrease) in cash and cash equivalents   2,718    (1,173)
           
Cash and cash equivalents at the beginning of the period   16,728    13,198 
           
Cash and cash equivalents at the end of the period  $19,446   $12,025 
           
Supplemental cash flow information:          
Cash paid for income taxes, net of (refunds)  $   $1,934 
Cash paid for interest  $11   $50 
           
Non-cash investing activities          
Accrued purchase of property and equipment  $239   $192 
Right-of-use assets obtained in exchange for lease obligations  $8   $ 

 

 

 6